Genedrive Regulatory News (GDR)

For release: 17 November 2017

2017 Annual Report and AGM Notice

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2017 Annual Report and Notice of the 2017 Annual General Meeting have been posted to shareholders. The AGM will be held at 12:00 on 29 November 2017 at the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.

Copies of these documents may be found on the Company's website (www.genedriveplc.com)

- Ends -

For further details please contact:

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has received CE-IVD Certification.

Further details can be found at: www.genedriveplc.com and www.genedrive.com